Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


The Value of Proton Therapy Discussed in Medscape Commentary

Note to Patients: The following news is posted for archival purposes only. Scripps is no longer accepting new patients for proton therapy.

Scripps proton therapy center exterior 2013

Carl Rossi, MD, medical director of the Scripps Proton Therapy Center, offers his perspectives on the value of proton therapy for treating prostate cancer in this recent “point-counterpoint” debate on Medscape.com. Dr. Rossi has treated more than 9,000 patients with prostate cancer over his 20-year career and has also taught, researched and written extensively about the disease.

Download the full article: Experts Debate Proton Therapy for Prostate Cancer (PDF, 180 KB)

Reprinted with permission from Medscape.

Media Contact

Steve Carpowich